The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool

The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure was developed to aid clinicians with a dimensional assessment of psychopathology; however, this measure resembles a screening tool for several symptomatic domains. The objective of the current study was to examine the basic parameters of sen...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatric quarterly 2018-03, Vol.89 (1), p.111-115
Main Authors: Bastiaens, Leo, Galus, James
Format: Article
Language:English
Subjects:
Adult
Affective disorders
Anxiety
Anxiety - diagnosis
Anxiety Disorders - diagnosis
Bipolar Disorder - diagnosis
Depression - diagnosis
Depressive Disorder - diagnosis
Diagnostic and Statistical Manual of Mental Disorders
False positive results
Female
Humans
Male
Mania
Medical screening
Medicine
Medicine & Public Health
Mental depression
Middle Aged
Original Paper
Power
Psychiatric Status Rating Scales - standards
Psychiatry
Psychopathology
Psychosis
Psychotic Disorders - diagnosis
Public Health
Self evaluation
Sensitivity and Specificity
Sociology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure was developed to aid clinicians with a dimensional assessment of psychopathology; however, this measure resembles a screening tool for several symptomatic domains. The objective of the current study was to examine the basic parameters of sensitivity, specificity, positive and negative predictive power of the measure as a screening tool. One hundred and fifty patients in a correctional community center filled out the measure prior to a psychiatric evaluation, including the Mini International Neuropsychiatric Interview screen. The above parameters were calculated for the domains of depression, mania, anxiety, and psychosis. The results showed that the sensitivity and positive predictive power of the studied domains was poor because of a high rate of false positive answers on the measure. However, when the lowest threshold on the Cross-Cutting Symptom Measure was used, the sensitivity of the anxiety and psychosis domains and the negative predictive values for mania, anxiety and psychosis were good. In conclusion, while it is foreseeable that some clinicians may use the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a screening tool, it should not be relied on to identify positive findings. It functioned well in the negative prediction of mania, anxiety and psychosis symptoms.
ISSN:0033-2720
1573-6709
DOI:10.1007/s11126-017-9518-7